Skip to main content
Log in

HIV-Associated Peripheral Neuropathy

Epidemiology, Pathophysiology and Treatment

  • Disease Management
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Peripheral neuropathy is the most frequent neurological complication associated with human immunodeficiency virus type 1 (HIV) infection and advanced acquired immunodeficiency syndrome (AIDS). There are at least 6 patterns of HIV-associated peripheral neuroathy, although these diagnoses are often overlooked or misdiagnosed.

Distal symmetrical polyneuropathy (DSP) is the most common form of peripheral neuropathy in HIV infection. DSP occurs mainly in patients with advanced immunosuppression and may also be secondary to the neurotoxicity of several antiretroviral agents. Treatment of painful DSP is primarily symptomatic, while pathogenesis-based therapies are under investigation. Reduction or discontinuation of neurotoxic agents should be considered if possible.

Inflammatory demyelinating polyneuropathy (IDP) can present in an acute or chronic form. The acute form may occur at the time of primary HIV infection or seroconversion. Cerebrospinal fluid lymphocytic pleocytosis (10 to 50 cells/mm3) is helpful in the diagnosis of HIV-associated IDP. Treatment consists of immunomodulatory therapy.

Progressive polyradiculopathy (PP) most commonly occurs in advanced immunosuppression and usually is caused by cytomegalovirus (CMV) infection. Rapidly progressive flaccid paraparesis, radiating pain and paresthesias, areflexia and sphincter dysfunction are the cardinal clinical features. Rapid diagnosis and treatment with anti-CMV therapy are necessary to prevent irreversible neurological deficits resulting from nerve root necrosis.

Mononeuropathy multiplex (MM) that occurs in early HIV infection is characterised by self-limited sensory and motor deficits in the distribution of individual peripheral nerves. In advanced HIV infection, multiple nerves in two or more extremities or cranial nerves are affected. Treatment includes immunomodulation or anti-CMV therapy.

Autonomic neuropathy may be caused by central or peripheral nervous system abnormalities. Treatment is supportive with correction of metabolic or toxic causes. Diffuse infiltrative lymphocytosis syndrome (DILS) presents as a Sjögren’slike disorder with CD8 T cell infiltration of multiple organs. Antiretroviral therapy and steroids may be effective treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Fig. 1

Similar content being viewed by others

References

  1. Simpson DM, Olney RK. Peripheral neuropathies associated with human immunodeficiency virus infection. In: Dyck PJ, editor. Peripheral neuropathies: new concepts and treatments. Philadelphia (PA): WB Saunders, 1992: 685–711

    Google Scholar 

  2. Simpson DM, Katzenstein DA, Hughes MD, the AIDS Clinical Trial Group 175/801 Study Team, et al. Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS 1998; 12: 2425–32

    Article  PubMed  CAS  Google Scholar 

  3. Tagliati M, Grinnel J, Goldbold J, et al. Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol 1999; 56: 84–9

    Article  PubMed  CAS  Google Scholar 

  4. Hall CD, Snyder CR, Mesenheimer JA, et al. Peripheral neuropathy in a cohort of human immunodeficiency virus infected patients: incidence and relationship to other nervous system dysfunction. Arch Neurol 1991; 48: 1273–4

    Article  PubMed  CAS  Google Scholar 

  5. Snider WD, Simpson DM, Nielsen S, et al. Neurological complications of acquired immunodeficiency syndrome: analysis of 50 patients. Ann Neurol 1983; 14: 403–18

    Article  PubMed  CAS  Google Scholar 

  6. Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1 related neurologic diseases: Multicenter AIDS Cohort Study, 1985–1992. Neurology 1994; 44: 1892–900

    Article  PubMed  CAS  Google Scholar 

  7. So YT, Holtzman DM, Abrams DJ, et al. Peripheral neuropathy associated with acquired immunodeficiency syndrome: prevalence and clinical features from a population-based survey. Arch Neurol 1988; 45: 945–8

    Article  PubMed  CAS  Google Scholar 

  8. Barohn RJ, Gronseth GS, LeForce BR, et al. Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals. Arch Neurol 1993;50: 167–71

    Article  PubMed  CAS  Google Scholar 

  9. Raphael SA, Price ML, Lischner HW, et al. Inflammatory demyelinating polyneuropathy in a child with symptomatic human immunodeficiency virus infection. J Pediatr 1991; 118: 242–5

    Article  PubMed  CAS  Google Scholar 

  10. Lacroix C, Vazeux R, Brousse N, et al. A neuropathological study of 10 HIV-infected children. Rev Neurol 1993; 149: 37–45

    PubMed  CAS  Google Scholar 

  11. Janssen RS, Saykin AJ, Kaplan JE, et al. Neurological complications of human immunodeficiency virus infection in patients with lymphadenopathy syndrome. Ann Neurol 1988; 23: 49–53

    Article  PubMed  CAS  Google Scholar 

  12. Villa A, Foresti V, Confalonieri F. Autonomic nervous system dysfunction associated with HIV infection in intravenous heroin users. AIDS 1992; 6: 85–9

    Article  PubMed  CAS  Google Scholar 

  13. Cohen JR, Laundenslager M. Autonomic nervous system involvement in patients with human immunodeficiency virus infection. Neurology 1989; 39: 1111–12

    Article  PubMed  CAS  Google Scholar 

  14. Gherardi RK, Chretien F, Defau-Larue H, et al. Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma. Neurology 1998; 50: 1041–4

    Article  PubMed  CAS  Google Scholar 

  15. Mah V, Vartavarian LM, Akers MA, et al. Abnormalities of peripheral nerve in patients with human immunodeficiency virus infection. Ann Neurol 1988; 24: 713–17

    Article  PubMed  CAS  Google Scholar 

  16. De la Monte SM, Gabuzda DH, Ho DD, et al. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol 1988; 23: 485–92

    Article  PubMed  Google Scholar 

  17. Lipkin WI, Parry G, Kiprov D, et al. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 1985; 35: 1479–83

    Article  PubMed  CAS  Google Scholar 

  18. Rance NE, McArthur JC, Cornblath D, et al. Gracile tract degeneration in patients with sensory neuropathy and AIDS. Neurology 1988; 38: 265–71

    Article  PubMed  CAS  Google Scholar 

  19. Said G, Saimot AG, Tardieu M et al. Peripheral nerve disease in HIV-infected patients. In: Warlow CP, van Ginj J, editors. Major problems in neurology: 34. Neurological complications of HIV and AIDS. London: WB Saunders Company Ltd, 1998: 155–80

    Google Scholar 

  20. Cornblath DR, McArthur JC, Kennedy PGE, et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 1987; 21: 32–40

    Article  PubMed  CAS  Google Scholar 

  21. Gherardi R, Labargy F, Mhiri C, et al. Necrotizing vasculitis and HIV replication in peripheral nerves [letter]. N Engl J Med 1989; 321: 685–6

    PubMed  CAS  Google Scholar 

  22. Eidelberg D, Sostrel A, Vogel H, et al. Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology 1986; 36: 912–16

    Article  PubMed  CAS  Google Scholar 

  23. Said G, Lacroix C, Chemuilli P, et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 1991; 29: 139–46

    Article  PubMed  CAS  Google Scholar 

  24. Batman PA, Miller ARO, Sedwick PM, et al. Autonomie denervation in jejunal mucosa of homosexual men infected with HIV. AIDS 1991; 5: 1247–52

    Article  PubMed  CAS  Google Scholar 

  25. Purba JS, Hoffman MA, Portegies P, et al. Decreased number of oxytoxin neurons in the paraventricular nucleus of the human hypothalamus in AIDS. Brain 1993; 116: 795–805

    Article  PubMed  Google Scholar 

  26. Wulff, EA, Simpson DM. HIV-associated neuropathy: recent advances in management. HIV Adv Res Ther 1998; 8(3): 23–9

    Google Scholar 

  27. Comblath DR, McArthur JC. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988; 38: 794–6

    Article  Google Scholar 

  28. Simpson DM, Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J AIDS 1995; 9: 153–61

    CAS  Google Scholar 

  29. Berger AR, Arezzo JC, Schaumburg HH, et al. 2′,3′-Dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology 1993; 43: 358–62

    Article  PubMed  CAS  Google Scholar 

  30. Fumalaro G, Moretti S, Marcellini S, et al. Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS 1997; 11: 185–90

    Article  Google Scholar 

  31. Gill P, Rarick M, Bernstein-Singer M, et al. Treatment of advanced Kaposi’s sarcoma using combination of bleomycin and vincristine. Am J Clin Oncol 1990; 13: 315–19

    Article  PubMed  CAS  Google Scholar 

  32. Figg WD. Peripheral neuropathy in HIV patients after isoniazid therapy. Drug Intell Clin Pharm 1991; 25: 100–1

    CAS  Google Scholar 

  33. Ochonoski S, Verroust J, Bastuji-Garin S, et al. Thalidomide neuropathy: incidence and clinicoelectrophysiological findings in 42 patients. Arch Dermatol 1994; 130: 66–9

    Article  Google Scholar 

  34. Vendrell J, Heredia C, Pujol M, et al. Guillain-Barre syndrome associated with seroconversion for anti-HTLV III. Neurology 1987; 37: 544

    Article  PubMed  CAS  Google Scholar 

  35. Misha BE, Sommers W, Koski CL, et al. Acute inflammatory demyelinating polyneuropathy in the acquired immunodeficiency syndrome. Ann Neurol 1985; 18: 131–2

    Google Scholar 

  36. Morgello S, Simpson DM. Multifocal cytomegalovirus demyelinating polyneuropathy associated with AIDS. Muscle Nerve 1994; 17: 176–82

    Article  PubMed  CAS  Google Scholar 

  37. Kim YS, Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 1993; 17: 32–7

    Article  PubMed  CAS  Google Scholar 

  38. Clifford DB, Buller RS, Mohammed S, et al. Use of polymerase chain reaction to demonstrate cytomegalovirus DNA in CSF of patients with human immunodeficiency virus infection. Neurology 1993; 43: 75–9

    Article  PubMed  CAS  Google Scholar 

  39. Miller RG, Parry CJ, Pfaeffl W, et al. The spectrum of peripheral neuropathy associated with ARC and AIDS. Muscle Nerve 1988; 11: 857–63

    Article  PubMed  CAS  Google Scholar 

  40. Roullet E, Assuerus V, Gozlan J, et al. Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive patients. Neurology 1994; 44: 2174–82

    Article  PubMed  CAS  Google Scholar 

  41. Freeman R, Roberts M, Friedman L, et al. Autonomic function and human immunodeficiency virus infection. Neurology 1990; 40: 575–80

    Article  PubMed  CAS  Google Scholar 

  42. Moulignier A, Authier FJ, Baudrimont M, et al. Peripheral neuropathy in HIV-infected patients with diffuse infiltrative lymphocytosis syndrome (DILS). Ann Neurol 1997; 41: 438–45

    Article  PubMed  CAS  Google Scholar 

  43. World Health Organization. Cancer pain relief, with a guide of opioid availability. 2nd ed. Geneva: World Health Organization, 1996

    Google Scholar 

  44. Kieburtz K, Simpson DM, Yiannoustsos C. A randomized trial of amitriptyline and mexiletene for painful neuropathy in HIV infection: the ACTG 242 Study Team. Neurology 1998; 51: 1682–8

    Article  PubMed  CAS  Google Scholar 

  45. Simpson DM, Olney R, McArthur J, et al. A placebo-controlled study of lamotrigine in the treatment of painful sensory polyneuropathy associated with HIV infection. Neurology. In press

  46. Dorfman D, Dalton A, Khan A, et al. Treatment of painful distal sensory polyneuropathy in HIV-infected patients with a topical agent: results of an open-label trial of 5% lidocaine gel. AIDS 1999; 13: 1589–90

    Article  PubMed  CAS  Google Scholar 

  47. Shlay JC, Chaloner D, Max M, et al. Acupunture and amitrptyline for pain due to HIV-related peripheral neuropathy. JAMA 1998; 280: 1590–5

    Article  PubMed  CAS  Google Scholar 

  48. Dyck PJ, Peroutka S, Rask C, et al. Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 1997; 48: 501–5

    Article  PubMed  CAS  Google Scholar 

  49. McArthur J, Yiannoutsos C, Simpson DM et al. A phase II trial of recombinant human nerve growth factor for sensory neuropathy associated with HIV. Neurology 2000; 54: 1080–8

    Article  PubMed  CAS  Google Scholar 

  50. Apfel SC, Kessler JA, Adornato BT, et al. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy: NGF Study Group. Neurology 1998; 51: 695–702

    Article  PubMed  CAS  Google Scholar 

  51. Jacobson MA. Treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. N Engl J Med 1997; 337(2): 105–14

    Article  PubMed  CAS  Google Scholar 

  52. So YT, Olney RK. The natural history of mononeuritis multiplex and simplex in HIV-infection. Neurology 1991; 41 Suppl. 1: 375

    Google Scholar 

  53. Freeman R. Autonomie failure and AIDS. In: Low PA, editor. Clinical autonomie disorders. Philadelphia (PA): Lippincott-Raven Publishers, 1997: 727–35

    Google Scholar 

  54. Fealey RD, Robertson D. Management of orthostatic hypotension. In: Low PA, editor. Clinical autonomie disorders. Philadelphia (PA): Lippincott-Raven Publishers, 1997: 763–75

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wulff, E.A., Wang, A.K. & Simpson, D.M. HIV-Associated Peripheral Neuropathy. Drugs 59, 1251–1260 (2000). https://doi.org/10.2165/00003495-200059060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200059060-00005

Keywords

Navigation